Ladner Patent Management LLC © ALL RIGHTS RESERVED. 

+1.203-464-0622

questions?

No Cost, No Obligation First Consultation

Ladner Patent Management LLC

David W. Ladner has a B.S. in Chemistry from The Pennsylvania State University and a Ph.D. in Synthetic Organic Chemistry from the University of Georgia, where he worked under the direction of Professor Richard K. Hill. Following two postdoctoral research associate positions, first at the University of Washington with Niels Andersen and then at Syntex, S.A. with Dr. Joseph Muchowski, Dr. Ladner became a Research Chemist with American Cyanamid in Princeton, NJ.  He designed, carried out and directed the synthesis of organic compounds useful for crop protection and is himself a named inventor on more than 20 U.S. patents. At Cyanamid he served as Group Leader, Senior Group Leader and a Research Manager in the Herbicide Discovery Section and was awarded the Cyanamid Scientific Achievement Award for his role in designing potent, selective, and short residual herbicides.


Dr. Ladner became a Registered Patent Agent in 2000 and was appointed as the Patent Liaison in Chemical Research for Bayer Pharmaceuticals in West Haven, CT.  He was responsible for drafting and assembling patent applications covering compounds useful in the treatment of Cancer, Diabetes, Obesity and Osteoporosis.  During that time he also earned an M.B.A. in Pharmaceutical Management from Fairleigh Dickinson University.

Since establishement in 2009, Ladner Patent Managment LLC has provided Patent Prosecution Services directly to individual clients, and in-house Patent Manager Consulting Services to numerous small and starup Pharmaceutical and Biotechnology companies, coordinating the IP efforts with inventors and outside counsel, and provides strategic guidance for the prosecution and maintenance of worldwide patent portfolios.

David W. Ladner has been a Registered Patent Agent (#45,516) since March 2000, and is member of the American Chemical Society, the National Association of Patent Practitioners, the American Intellectual Property Law Association and Alpha Chi Sigma.